Rotational atherectomy followed by drug-eluting stent implantation (Rota-DES): a rational approach for complex

A A Khattab1, G Richardt

  • 1The Heart and Vascular Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany. ahmed.khattab@segebergerkliniken.de

Insights

Rotational atherectomy, after falling out of favor, is resurging for complex percutaneous coronary interventions (PCI) with drug-eluting stents (DES). Research suggests pre-stent atherectomy may improve long-term outcomes, enhancing DES effectiveness.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Surgery
  • Medical Devices

Background:

  • Rotational atherectomy use declined due to unproven long-term benefits in percutaneous coronary interventions (PCI).
  • The advent of drug-eluting stents (DES) has enabled PCI for more complex lesions and high-risk patients.
  • Off-label DES use is linked to increased stent thrombosis, necessitating improved implantation techniques like aggressive lesion preparation.

Purpose of the Study:

  • To evaluate the role of rotational atherectomy in preparing complex coronary lesions before drug-eluting stent implantation.
  • To assess the potential add-on effect of rotational atherectomy on long-term outcomes when combined with DES.
  • To highlight the importance of interventional training for rotational atherectomy techniques.

Main Methods:

  • Review of limited studies on rotational atherectomy preceding DES implantation.
  • Observation of promising short-term results and no long-term safety concerns in initial studies.
  • An ongoing multicenter study investigating the effect of rotational atherectomy on complex calcified lesions before DES implantation.

Main Results:

  • Limited studies indicate rotational atherectomy prior to DES implantation shows promising results with no immediate safety concerns.
  • A subtle observation suggests a potential long-term benefit of rotational atherectomy before DES implantation.
  • Rotational atherectomy is an effective tool for preparing challenging lesions to facilitate safe and effective DES delivery and expansion.

Conclusions:

  • Rotational atherectomy is regaining importance for complex PCI, particularly with DES, due to its lesion preparation capabilities.
  • Further research, including ongoing multicenter studies, is needed to confirm the long-term benefits of rotational atherectomy with DES.
  • Interventional cardiology training programs must re-emphasize rotational atherectomy techniques to address the experience gap.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...